Skip to content

Similar papers

Review Open access Aug 2026

Adjunctive nutraceutical strategies in ulcerative colitis: From molecular pathways to clinical outcomes.

Ulcerative colitis is a chronic inflammatory disease of the large intestine, involving flare-ups and remissions. Its exact causes are unclear, but genetic susceptibility, immune dysregulation and environmental influences promote development. Conventional treatments have improved management, but some patients only respo...

C. Caputo, Azzurra Chiara De Maio, Angela Lombardi et al. · 0 citations
Review Aug 2026

Advances in Probiotic Research: Mechanisms of Action, Clinical Benefits, and Future Directions

Probiotics represent an evolving field that holds great promise for novel approaches to improve preventive medicine and disease management through personalized healthcare as well as furthering evidence-based microbiome medicine.

Assit.Prof.RADHIKA C.WARADE · 0 citations
Sep 2026

Engineered Calprotectin-Responsive Probiotics for Inflammatory Bowel Disease Treatment

Inflammatory bowel disease (IBD) is a complex intestinal disorder for which effective treatment options remain limited. The modulation of gut microbiota balance using probiotics holds promise as a therapeutic approach to restore intestinal microenvironment homeostasis. However, the clinical translation of conventiona...

Fan Yang, Li-Na He, Xiang Lin et al. · 0 citations
Review Open access Jan 2026

Probiotics in Human Health: Current Evidence, Mechanism of Action, and Future Perspectives

This narrative review provides an integrated overview of current knowledge on probiotic functionality, highlights emerging therapeutic opportunities, and identifies key research gaps that should be addressed to support evidence‐based probiotic use.

Guesh Mulaw, Gebrekidan Kidanemariam, M. Bara et al. · 1 citation
Review Open access Oct 2026

Probiotics in type 1 diabetes: immunomodulatory mechanisms and the unresolved question of clinical efficacy

Type 1 Diabetes (T1D) is a common autoimmune disease worldwide, which is associated with imbalanced gut microbiota. Intestinal dysbiosis plays a key role in the pathogenesis of T1D, and it may affect immune tolerance and autoimmune responses of pancreatic islet β-cells. As a potential immunomodulator, probiotics can he...

Simiao Chen, Lu Wang, Shuo-Tong Zhang et al. · 0 citations
Conference Open access 2026

A Study on the Mechanism of Curcumin in Improving Ulcerative Colitis

The study found that curcumin improves physiological indicators such as survival rate and body weight in UC-affected mice and alleviates pathological damage to intestinal tissue, and the therapeutic effects were more pronounced in the high-concentration curcumin group and the treatment group receiving curcumin combined...

Jing-Zhe Chen · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.